Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J. M. Pérez-Pariente"'
Autor:
L. Rodrigo, J. M. Pérez-Pariente, D. Fuentes, V. Cadahia, A. García-Carbonero, P. Niño, R. de Francisco, R. Tojo, M. Moreno, E. González-Ballina
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 96, Iss 8, Pp 548-558 (2004)
Objectives: infliximab has clearly demonstrated its efficacy in the short-term treatment of fistulizing Crohn' disease. We present here the results of retreatment and long-term maintenance therapy. Patients and methods: eighty one consecutive patient
Externí odkaz:
https://doaj.org/article/0b8808fb3fb74c09a884208cd9d2dde7
Autor:
R. Tojo, V. Cadahía, R. de Francisco, Luis Rodrigo, J. M. Pérez-Pariente, Mercedes Rodríguez, Raúl J. Andrade, Lucena Mi
Publikováno v:
Scandinavian Journal of Gastroenterology. 37:1341-1343
We present the case of a 63-year-old woman who had undergone 7 months of treatment with Nimesulide (100 mg/b.i.d.) for symptomatic osteoarthritis. The patient was admitted to our unit with a clinical picture of progressive jaundice over 3 weeks. Clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe01a1013480a2bf1300a9177c90001
https://doi.org/10.1080/003655202761020650
https://doi.org/10.1080/003655202761020650
Autor:
V. Cadahía, A. García-Carbonero, L. Rodrigo, E. Gonzalez-Ballina, R. de Francisco, Dolores Fuentes, J. M. Pérez-Pariente, P. Niño, María de Lourdes Moreno, R. Tojo
Publikováno v:
Revista Española de Enfermedades Digestivas v.96 n.8 2004
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Objectives: infliximab has clearly demonstrated its efficacy in the short-term treatment of fistulizing Crohn' disease. We present here the results of retreatment and long-term maintenance therapy. Patients and methods: eighty one consecutive patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c49c91fa057843d096dfa1df1e8268
https://doi.org/10.4321/s1130-01082004000800004
https://doi.org/10.4321/s1130-01082004000800004
Autor:
Segundo Gonzalez, Eva M Deschamps, Jesús Martínez-Borra, J. M. Pérez-Pariente, Luis Rodrigo, Angeles Dieguez, Carlos López-Larrea, Dolores Fuentes, Antonio López-Vázquez, Ruth de Francisco
Publikováno v:
The American journal of gastroenterology. 97(9)
Infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor-alpha (anti-TNF-alpha), has been effective in the treatment of patients with active Crohn's disease and with fistulas. We investigated the effect of infliximab on circu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183a4b8bba98e52efec4540e48ae45c3
https://pubmed.ncbi.nlm.nih.gov/12358255
https://pubmed.ncbi.nlm.nih.gov/12358255
Autor:
A, Villán González, M, Rivela Vázquez, H, Bernardo Fernández, J, Vegas San Martín, L, Hernández Luyando, J M, Pérez-Pariente
Publikováno v:
Revista clinica espanola. 202(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::becd013e4612e36fe64e996d30e21463
https://pubmed.ncbi.nlm.nih.gov/11996747
https://pubmed.ncbi.nlm.nih.gov/11996747